Bioauxilium is a private Canadian biotechnology company founded by seasoned scientists from PerkinElmer. The company is focused on the design, development and manufacturing of top-quality, fully-validated assay kits that simplify laboratory workflow and accelerate biomedical research.
Since its inception in 2013, Bioauxilium has licensed hundreds of TR FRET assay kits enabling the quantification of cellular proteins and biomarkers. Bioauxilium’s kits are based on its proprietary THUNDER™ TR-FRET technology. They are offered at an outstanding value and are supported by expert technical support. Bioauxilium also provides on a contract basis customized services in assay development using diverse cutting-edge technologies.
■ Custom TR-FRET-based immunoassay kit development and manufacturing
■ Conversion of ELISAs into homogeneous immunoassays (TR-FRET, AlphaLISA) amenable to automation using your antibody pair or our “best pair” screening service
■ Custom labeling: labeling of biomolecules with lanthanides, fluorophores or biotin to build reagent tools necessary for assay development
■ Custom biochemical, cell-based and biomarker assay development using multiple technology platforms (absorbance, fluorescence, FP, TRF, TR-FRET, luminescence, AlphaScreen, AlphaLISA)
■ Assay design, development, optimization and validation for drug discovery research, from HTS to lead optimization